在子宫表皮中过度的脂质过氧化会导致植入失败和怀孕流产
Yafang Lu1, Yuhan Shao2,3, Weiwei Cui4
1Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|December 3, 2023
概括
保护子宫氧化还原平衡是成功植入胚胎的关键. 在子宫上皮细胞中删除Glutathione peroxidase 4 (GPX4) 通过增加脂质过氧化导致不孕,突出了GPX4.
科学领域:
- 生殖生物学 生殖生物学
- 细胞生理学 细胞生理学
- 氧化应激研究研究 氧化应激研究
背景情况:
- 子宫的受容性对于怀孕早期的成功至关重要.
- 氧化还原稳定,特别是脂质过氧化物水平,对细胞功能至关重要.
- 在子宫受体性和胚胎植入方面,氧化还原平衡的具体作用以前尚不清楚.
研究的目的:
- 在胚胎植入过程中调查谷氨酸过氧化酶4 (GPX4) 在子宫上皮细胞中的作用.
- 为了确定脂质过氧化对子宫受体性和早期怀孕的影响.
- 探索与氧化还原失衡相关的植入缺陷的潜在治疗策略.
主要方法:
- 在小鼠中使用乳酸转移素 (Ltf) -Cre驱动剂对Gpx4进行子宫特异性删除.
- 脂质过氧化抑制剂的使用.
- 植入成功的评估和子宫受体性标志物.
- 对蛋白质碳化和脂质反应性氧物种水平的分析.
主要成果:
- 对于子宫表皮的特定删除GPX4导致不孕症,以缺陷植入为特征.
- 在Gpx4被删除的小鼠中观察到子宫表皮中的脂肪过氧化增加.
- 脂质过氧化抑制剂未能挽救植入,这表明更深层的分子损伤.
- 与GPX4删除保持生殖能力的Acyl-CoA合成酶长链家族成员4 (ACSL4) 的同时表达,表明了复杂的相互作用.
结论:
- 不平衡的氧化还原信号,特别是子宫上皮细胞中的高脂类过氧化,会对胚胎植入产生不利影响.
- GPX4对于维持子宫受体性和成功怀孕至关重要.
- 向和减少脂质过氧化物可能为预防植入失败提供治疗途径.
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Ovarian Cycle
1.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.3K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


